B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.

Medically reviewed by Archana Sharma, DO Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of ...

Using the National Cancer Database, this retrospective cohort study identified 23,397 ALL patients between the ages of 0-18 who received chemotherapy from 2004-2020. Patients with race listed as ...

Recent advances in chimeric antigen receptors have provided an alternative approach for treating relapsed acute lymphocyte leukemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...

Recent progress in the molecular genetics of acute myeloid leukemia (AML) has shown this disease to be more heterogeneous than previously realized. Recurrent cytogenetic and mutational changes in ...

Except when given into the CSF, these drugs enter the bloodstream and reach all areas of the body, making this treatment useful for cancers such as leukemia that spread throughout the body. Phases of ...

Acute myeloid leukemia (AML) can cause many different signs and symptoms. Some are more common with certain subtypes of AML. More often these symptoms are caused by something other than leukemia. But ...

How TKIs Have Changed Frontline Treatment of Ph-Positive ALL Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph-positive ALL) is the most common genetic ALL subgroup in adulthood ...

Background: Relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (R/R Ph + ALL) and chronic myeloid leukemia in the blast phase (CML-BP) are associated with poor ...